AMEH - Apollo Medical Holdings Inc Stock Price, Fair Value and News

40.80USD-0.10 (-0.24%)Market Closed

Market Summary

USD40.80-0.10

Market Closed

-0.24%

AMEH Stock Price

View Fullscreen

AMEH RSI Chart

AMEH Valuation

Market Cap

2.3B

Price/Earnings (Trailing)

36.62

Price/Sales (Trailing)

1.57

EV/EBITDA

17.38

Price/Free Cashflow

52.41

AMEH Price/Sales (Trailing)

AMEH Profitability

EBT Margin

6.50%

Return on Equity

9.49%

Return on Assets

5.09%

Free Cashflow Yield

1.91%

AMEH Fundamentals

AMEH Revenue

Revenue (TTM)

1.5B

Rev. Growth (Yr)

19.9%

Rev. Growth (Qtr)

14.54%

AMEH Earnings

Earnings (TTM)

62.4M

Earnings Growth (Yr)

12.97%

Earnings Growth (Qtr)

20.06%

Breaking Down AMEH Revenue

Last 7 days

4.9%

Last 30 days

9.1%

Last 90 days

6.0%

Trailing 12 Months

20.5%

How does AMEH drawdown profile look like?

AMEH Financial Health

Current Ratio

1.52

Debt/Equity

0.56

Debt/Cashflow

0.18

AMEH Investor Care

Buy Backs (1Y)

2.64%

Diluted EPS (TTM)

1.32

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.5B	0	0	0
2023	1.2B	1.3B	1.3B	1.4B
2022	861.1M	955.2M	1.0B	1.1B
2021	698.1M	708.6M	755.6M	773.9M
2020	630.0M	695.2M	705.7M	717.4M
2019	491.7M	499.1M	488.5M	560.6M
2018	394.9M	476.0M	545.6M	519.9M
2017	128.0M	157.2M	239.7M	356.4M
2016	44.0M	46.2M	49.5M	54.5M
2015	33.0M	39.1M	38.8M	41.8M
2014	10.8M	12.1M	20.9M	25.7M
2013	6.6M	7.1M	9.3M	10.3M
2012	5.1M	5.7M	6.3M	6.8M
2011	3.9M	4.2M	4.5M	4.8M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Apollo Medical Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 23, 2024	kumar dinesh m.	acquired	-	-	150,395	see remarks
Dec 15, 2023	marsh linda	acquired	-	-	3,650	-
Dec 15, 2023	mazdyasni matthew	acquired	-	-	4,750	-
Dec 15, 2023	vong john	acquired	-	-	14,352	chief accounting officer
Dec 15, 2023	dai, weili	acquired	-	-	3,650	-
Dec 15, 2023	chiang john	acquired	-	-	4,750	-
Dec 15, 2023	schmidt david	acquired	-	-	5,750	-
Dec 15, 2023	lam thomas s.	acquired	-	-	90,000	president and co-ceo
Dec 15, 2023	sim kenneth t.	acquired	-	-	90,000	executive chairman
Dec 15, 2023	kitayama mitchell w	acquired	-	-	6,750	-

Which funds bought or sold AMEH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	added	1.76	201,483	1,944,100	-%
May 16, 2024	HANCOCK WHITNEY CORP	reduced	-1.95	28,399	407,304	0.01%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-80.86	-1,587,040	421,412	-%
May 16, 2024	COMERICA BANK	reduced	-8.46	2,828	787,038	-%
May 15, 2024	AMERIPRISE FINANCIAL INC	reduced	-1.8	370,417	5,203,150	-%
May 15, 2024	Centiva Capital, LP	sold off	-100	-226,506	-	-%
May 15, 2024	KENNEDY CAPITAL MANAGEMENT LLC	sold off	-100	-1,464,860	-	-%
May 15, 2024	JANUS HENDERSON GROUP PLC	added	0.2	70,822	786,119	-%
May 15, 2024	UBS ASSET MANAGEMENT AMERICAS LLC	unchanged	-	187,481	2,133,430	-%
May 15, 2024	STATE STREET CORP	added	3.81	8,178,940	67,414,500	-%

Are Funds Buying or Selling AMEH?

Are funds buying AMEH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AMEH

No. of Funds

Unveiling Apollo Medical Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	8.66%	5,049,928	SC 13G/A
Jan 23, 2024	blackrock inc.	13.5%	6,498,075	SC 13G/A
Nov 17, 2023	allied physicians of california, a profession medical corp	12.9%	7,132,698	SC 13D/A
Feb 09, 2023	vanguard group inc	7.83%	4,438,955	SC 13G/A
Jan 26, 2023	blackrock inc.	11.5%	6,514,440	SC 13G/A
Jan 20, 2023	blackrock inc.	11.5%	6,514,440	SC 13G/A
Feb 09, 2022	vanguard group inc	7.02%	3,897,315	SC 13G
Jan 28, 2022	blackrock inc.	10.7%	5,960,508	SC 13G/A
Oct 08, 2021	blackrock inc.	10.6%	5,867,352	SC 13G
Jul 08, 2021	allied physicians of california, a profession medical corp	20.0%	10,993,301	SC 13D/A

Recent SEC filings of Apollo Medical Holdings Inc

View All Filings

Date Filed	Form Type	Document
May 17, 2024	4	Insider Trading
May 15, 2024	8-K	Current Report
May 14, 2024	4	Insider Trading
May 09, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Apr 24, 2024	8-K	Current Report
Apr 24, 2024	8-K	Current Report
Apr 24, 2024	ARS	ARS
Apr 24, 2024	DEF 14A	DEF 14A
Apr 24, 2024	DEFA14A	DEFA14A

Peers (Alternatives to Apollo Medical Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Apollo Medical Holdings Inc News

Latest updates

Apollo Medical Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Revenue	14.5%	404	353	348	348	337	294	317	270	263	195	227	176	176	177	180	165	195	165	179	156	130
Costs and Expenses	4.9%	374	357	309	321	315	282	267	254	237	193	174	155	154	137	143	152	189	161	168	146	115
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	168	146	115
S&GA Expenses	-100.0%	-	38.00	29.00	24.00	21.00	24.00	21.00	20.00	12.00	17.00	22.00	14.00	9.00	9.00	16.00	12.00	-	12.00	11.00	8.00	12.00
EBITDA Margin	2.9%	0.09*	0.09*	0.10*	0.10*	0.09*	0.10*	0.07*	0.03*	0.11*	0.13*	0.20*	0.27*	-	-	-	-	-	-	-	-	-
Interest Expenses	39.9%	8.00	5.00	4.00	4.00	3.00	3.00	2.00	2.00	1.00	1.00	1.00	2.00	2.00	1.00	2.00	3.00	-	3.00	3.00	1.00	0.00
Income Taxes	601.9%	7.00	1.00	10.00	14.00	7.00	11.00	17.00	5.00	7.00	-4.28	-0.28	28.00	8.00	13.00	11.00	32.00	-	2.00	2.00	4.00	4.00
Earnings Before Taxes	2499.2%	24.00	1.00	38.00	31.00	19.00	10.00	41.00	17.00	18.00	-22.43	-5.50	84.00	21.00	24.00	36.00	113	6.00	5.00	0.00	14.00	15.00
EBT Margin	0.3%	0.06*	0.06*	0.07*	0.08*	0.07*	0.08*	0.05*	0.01*	0.09*	0.10*	0.16*	0.23*	-	-	-	-	-	-	-	-	-
Net Income	20.1%	15.00	12.00	22.00	13.00	13.00	-3.73	23.00	12.00	14.00	12.00	34.00	10.00	12.00	10.00	17.00	7.00	6.00	4.00	7.00	4.00	4.00
Net Income Margin	-1.9%	0.04*	0.04*	0.03*	0.04*	0.04*	0.04*	0.06*	0.08*	0.08*	0.09*	0.09*	0.07*	-	-	-	-	-	-	-	-	-
Free Cashflow	-54.2%	6.00	12.00	11.00	14.00	2.00	84.00	-39.08	8.00	7.00	-14.99	42.00	14.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	31.4%	1,226	933	1,073	1,027	999	966	955	967	923	867	871	896	843	817	814	833	724	729	750	568	521
Current Assets	16.8%	539	462	476	465	455	428	446	468	445	404	427	472	370	339	367	381	318	329	321	168	177
Cash Equivalents	14.2%	335	294	274	294	275	288	184	234	238	233	205	177	206	194	166	152	81.00	104	230	53.00	93.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12.00	12.00	12.00
Goodwill	47.1%	410	279	276	274	269	269	251	247	246	246	237	232	232	232	239	239	239	239	237	209	186
Liabilities	48.1%	774	523	458	444	434	408	410	447	397	357	346	356	382	372	386	414	369	368	382	163	126
Current Liabilities	62.5%	355	219	203	186	173	149	156	185	156	115	115	126	123	115	131	153	107	105	105	78.00	88.00
Long Term Debt	42.3%	368	259	206	205	205	203	199	199	183	183	183	183	227	230	226	230	230	232	234	-	-
LT Debt, Current	6.4%	21.00	20.00	3.00	3.00	1.00	1.00	3.00	2.00	2.00	1.00	0.00	0.00	12.00	11.00	10.00	10.00	10.00	10.00	10.00	-	-
LT Debt, Non Current	-100.0%	-	259	206	205	205	203	199	199	183	183	183	183	227	230	226	230	230	232	234	-	-
Shareholder's Equity	7.1%	658	614	594	570	551	543	504	480	473	454	435	399	347	329	229	208	198	192	192	186	182
Retained Earnings	6.1%	258	243	231	209	196	182	186	163	151	137	125	90.00	80.00	68.00	60.00	43.00	36.00	32.00	25.00	21.00	18.00
Additional Paid-In Capital	6.6%	395	371	363	357	353	360	315	311	316	311	306	306	266	261	169	164	161	160	166	164	163
Shares Outstanding	1.3%	47.00	47.00	47.00	47.00	46.00	47.00	45.00	45.00	45.00	45.00	44.00	44.00	-	-	-	-	-	-	-	-	-
Minority Interest	84.3%	4.00	2.00	4.00	4.00	3.00	2.00	3.00	6.00	6.00	6.00	4.00	3.00	1.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Float	-	-	-	-	1,300	-	-	-	1,500	-	-	-	2,400	-	-	-	504	-	-	-	480	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-69.0%	5,977	19,300	15,405	25,802	7,720	84,939	-35,870	9,021	24,038	-12,190	51,239	21,334	9,952	-2,601	36,189	21,868	-9,293	3,588	32,102	-18,050	-3,967
Share Based Compensation	-33.7%	5,748	8,676	5,706	4,213	3,445	5,624	3,502	3,920	3,055	2,423	1,420	1,556	1,346	825	600	900	1,058	541	330	331	345
Cashflow From Investing	-521.7%	-71,039	-11,427	-34,875	-5,186	-14,035	13,201	-8,086	7,497	-19,725	39,084	-12,742	-10,494	692	29,096	-753	68,093	-943	-120,267	-10,117	-50,135	-112
Cashflow From Financing	786.8%	106,351	11,993	-510	-963	-7,099	5,871	-6,251	-20,237	532	1,435	-11,016	-39,429	1,262	647	-21,795	-18,487	-12,061	-10,376	152,076	31,441	-9,810
Dividend Payments	-100.0%	-	59,808	1,424	722	120	1,354	120	11,378	1,178	-	9,979	21,106	4.00	1,186	19,946	-	9,934	1,047	49,728	942	10,000
Buy Backs	-	-	-	150	9,539	-	-423	168	9,300	230	-	2,758	2,639	342	-1,022	771	362	426	7,530	-	-	40.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AMEH Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Total revenue	$ 404,356	$ 337,244
Operating expenses
Cost of services, excluding depreciation and amortization	330,399	289,397
General and administrative expenses	38,722	21,182
Depreciation and amortization	5,096	4,292
Total expenses	374,217	314,871
Income from operations	30,139	22,373
Other income (expense)
Income from equity method investments	632	2,484
Interest expense	(7,585)	(3,269)
Interest income	3,996	3,009
Unrealized gain (loss) on investments	1,099	(6,392)
Other (loss) income	(4,277)	1,204
Total other expenses, net	(6,135)	(2,964)
Income before provision for income taxes	24,004	19,409
Provision for income taxes	7,142	6,921
Net income	16,862	12,488
Net income (loss) attributable to non-controlling interest	2,027	(644)
Net income attributable to Astrana Health, Inc.	$ 14,835	$ 13,132
Earnings per share – basic (in dollars per share)	$ 0.31	$ 0.28
Earnings per share – diluted (in dollars per share)	$ 0.31	$ 0.28
Capitation, net
Revenue
Total revenue	$ 365,910	$ 300,204
Risk pool settlements and incentives
Revenue
Total revenue	17,377	13,462
Management fee income
Revenue
Total revenue	4,078	9,896
Fee-for-service, net
Revenue
Total revenue	15,937	12,062
Other revenue
Revenue
Total revenue	$ 1,054	$ 1,620

AMEH Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Mar. 31, 2024

Dec. 31, 2023

Current assets

Cash and cash equivalents

$ 334,796

$ 293,807

Investment in marketable securities

2,490

2,498

Income taxes receivable

10,657

Other receivables

1,783

1,335

Prepaid expenses and other current assets

17,281

17,450

Total current assets

538,810

461,507

Non-current assets

Land, property and equipment, net

7,985

7,171

Intangible assets, net

119,707

71,648

Goodwill

410,267

278,831

Income taxes receivable

15,943

Investments in other entities – equity method

35,893

25,774

Investments in privately held entities

6,396

Restricted cash

645

345

Operating lease right-of-use assets

39,152

37,396

Other assets

4,067

1,877

Total non-current assets

687,467

471,854

Total assets

^[1]

1,226,277

933,361

Current liabilities

Accounts payable and accrued expenses

146,473

59,949

Fiduciary accounts payable

7,792

7,737

Medical liabilities

136,494

106,657

Income taxes payable

5,522

Dividend payable

638

Finance lease liabilities

636

646

Operating lease liabilities

5,007

4,607

Current portion of long-term debt

20,750

19,500

Other liabilities

31,960

18,940

Total current liabilities

355,272

218,674

Non-current liabilities

Deferred tax liability

3,756

4,072

Finance lease liabilities, net of current portion

1,015

1,033

Operating lease liabilities, net of current portion

37,716

36,289

Long-term debt, net of current portion and deferred financing costs

368,448

258,939

Other long-term liabilities

7,652

3,586

Total non-current liabilities

418,587

303,919

Total liabilities

^[1]

773,859

522,593

Commitments and contingencies (Note 12)

Mezzanine equity

Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")

(205,557)

(205,883)

Stockholders’ equity

Common stock, value, issued

Additional paid-in capital

395,473

371,037

Retained earnings

257,969

243,134

Total stockholders’ equity

653,490

614,218

Non-controlling interest

4,485

2,433

Total equity

657,975

616,651

Total liabilities, mezzanine equity and equity

1,226,277

933,361

Series A Preferred Stock

Stockholders’ equity

Preferred stock

Series B Preferred Stock

Stockholders’ equity

Preferred stock

Nonrelated Party

Current assets

Receivables, net

120,106

76,780

Non-current assets

Loans receivable, non-current

47,412

26,473

Related Party

Current assets

Receivables, net

$ 62,354

$ 58,980

[1]

The Company’s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $717.5 million and $540.8 million as of March 31, 2024 and December 31, 2023, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $179.6 million and $146.0 million as of March 31, 2024 and December 31, 2023, respectively. These VIE balances do not include $299.5 million of investment in affiliates and $110.1 million of amounts due to affiliates as of March 31, 2024, and $273.2 million of investment in affiliates and $107.3 million of amounts due to affiliates as of December 31, 2023, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 — “Variable Interest Entities (VIEs)” for further details.

About Apollo Medical Holdings Inc

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

CEO	Dr. Thomas S. Lam M.D., M.P.H.
WEBSITE	apollomed.net
INDUSTRY	Healthcare Plans
EMPLOYEES	1362

Apollo Medical Holdings Inc Frequently Asked Questions

What is the ticker symbol for Apollo Medical Holdings Inc? What does AMEH stand for in stocks?

AMEH is the stock ticker symbol of Apollo Medical Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Apollo Medical Holdings Inc (AMEH)?

As of Fri May 17 2024, market cap of Apollo Medical Holdings Inc is 2.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers.

What is the fair value of AMEH stock?

You can check AMEH's fair value in chart for subscribers. The fair value of Apollo Medical Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Apollo Medical Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMEH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Apollo Medical Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether AMEH is over valued or under valued. Whether Apollo Medical Holdings Inc is cheap or expensive depends on the assumptions which impact Apollo Medical Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMEH.

What is Apollo Medical Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, AMEH's PE ratio (Price to Earnings) is 36.62 and Price to Sales (PS) ratio is 1.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMEH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Apollo Medical Holdings Inc's stock?

In the past 10 years, Apollo Medical Holdings Inc has provided 0.25 (multiply by 100 for percentage) rate of return.